Editorial: The EXCEL Trial.
作者信息
Avanzas Pablo, Kaski Juan Carlos
机构信息
Heart Area, Hospital Universitario Central de Asturias Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) Oviedo, Spain.
出版信息
Eur Cardiol. 2021 Mar 30;16:e09. doi: 10.15420/ecr.2021.02. eCollection 2021 Feb.
Abstract
摘要
相似文献
1
Editorial: The EXCEL Trial.社论：EXCEL 试验
Eur Cardiol. 2021 Mar 30;16:e09. doi: 10.15420/ecr.2021.02. eCollection 2021 Feb.
2
Applicability of the EXCEL Trial Criteria to an All-Comers Real-World Cohort of Unprotected Left Main Percutaneous Coronary Intervention.EXCEL 试验标准在未经保护的左主干经皮冠状动脉介入治疗全人群真实世界队列中的适用性。
Am J Cardiol. 2023 May 15;195:98-106. doi: 10.1016/j.amjcard.2023.01.024. Epub 2023 Feb 18.
3
Efficacy and safety of a second-generation biodegradable polymer sirolimus-eluting stent: One-year results of the CREDIT 2 trial.第二代可生物降解聚合物西罗莫司洗脱支架的疗效和安全性：CREDIT 2 试验的一年结果。
Cardiovasc Ther. 2018 Jun;36(3):e12327. doi: 10.1111/1755-5922.12327. Epub 2018 Mar 25.
4
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.根据 EXCEL 试验入组标准的新一代药物洗脱支架治疗左主干冠状动脉疾病：来自所有患者、国际、多中心 DELTA-2 注册研究的见解。
Int J Cardiol. 2019 Apr 1;280:30-37. doi: 10.1016/j.ijcard.2018.12.003. Epub 2018 Dec 15.
5
Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization.贝叶斯解读 EXCEL 试验及其他左主干冠状动脉血运重建随机临床试验。
JAMA Intern Med. 2020 Jul 1;180(7):986-992. doi: 10.1001/jamainternmed.2020.1647.
6
A Chance to Grow and Excel as an Associate Editor of -Editorial.作为《编辑》副主编成长与卓越的机会。
Pharmacol Rev. 2024 May 2;76(3):321-322. doi: 10.1124/pharmrev.124.001101.
7
Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.左主干病变行冠状动脉旁路移植术后的当代结局。
J Am Coll Cardiol. 2019 Apr 23;73(15):1877-1886. doi: 10.1016/j.jacc.2018.12.090.
8
Impact of non-respect of SYNTAX score II recommendation for surgery in patients with left main coronary artery disease treated by percutaneous coronary intervention: an EXCEL substudy.经皮冠状动脉介入治疗的左主干冠状动脉疾病患者中不遵循SYNTAX评分II手术推荐的影响：EXCEL子研究
Eur J Cardiothorac Surg. 2020 Apr 1;57(4):676-683. doi: 10.1093/ejcts/ezz274.
9
Simple Excel and ICD-10 based dataset calculator for the Charlson and Elixhauser comorbidity indices.基于 Excel 和 ICD-10 的简单数据集计算器，用于计算 Charlson 和 Elixhauser 合并症指数。
BMC Med Res Methodol. 2022 Jan 7;22(1):4. doi: 10.1186/s12874-021-01492-7.
10
Excel-SBOL Converter: Creating SBOL from Excel Templates and Vice Versa.Excel-SBOL 转换器：从 Excel 模板创建 SBOL 以及反之亦然。
ACS Synth Biol. 2023 Jan 20;12(1):340-346. doi: 10.1021/acssynbio.2c00521. Epub 2023 Jan 3.
本文引用的文献
1
PCI or CABG for Left Main Coronary Artery Disease. Reply.左主干冠状动脉疾病的经皮冠状动脉介入治疗（PCI）或冠状动脉旁路移植术（CABG）。回复。
N Engl J Med. 2020 Jul 16;383(3):292-294. doi: 10.1056/NEJMc2000645.
2
PCI or CABG for Left Main Coronary Artery Disease.左主干冠状动脉疾病的经皮冠状动脉介入治疗（PCI）或冠状动脉旁路移植术（CABG）
N Engl J Med. 2020 Jul 16;383(3):290-291. doi: 10.1056/NEJMc2000645.
3
Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization.贝叶斯解读 EXCEL 试验及其他左主干冠状动脉血运重建随机临床试验。
JAMA Intern Med. 2020 Jul 1;180(7):986-992. doi: 10.1001/jamainternmed.2020.1647.
4
Left Main Coronary Artery Interventions.左主干冠状动脉介入治疗
Interv Cardiol. 2019 Nov 18;14(3):124-130. doi: 10.15420/icr.2019.10.R2. eCollection 2019 Nov.
5
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.左主干冠状动脉疾病经皮冠状动脉介入治疗或冠状动脉旁路移植术后 5 年的结果。
N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28.
6
'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南的“十诫”
Eur Heart J. 2019 Jan 7;40(2):79-80. doi: 10.1093/eurheartj/ehy855.
7
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.依维莫司洗脱支架或旁路移植术治疗左主干冠状动脉疾病。
N Engl J Med. 2016 Dec 8;375(23):2223-2235. doi: 10.1056/NEJMoa1610227. Epub 2016 Oct 31.
8
Left main coronary artery disease: importance, diagnosis, assessment, and management.左主干冠状动脉疾病：重要性、诊断、评估及管理
Curr Probl Cardiol. 2015 Mar;40(3):93-126. doi: 10.1016/j.cpcardiol.2014.11.003. Epub 2014 Nov 14.
9
Methods in health service research. An introduction to bayesian methods in health technology assessment.卫生服务研究方法。卫生技术评估中的贝叶斯方法介绍。
BMJ. 1999 Aug 21;319(7208):508-12. doi: 10.1136/bmj.319.7208.508.
10
Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes.使用贝叶斯分析将试验置于背景中。贝叶斯牧师对GUSTO的重新审视。
JAMA. 1995 Mar 15;273(11):871-5.
Zotero 插件